Patients' needs in hematology: whose perspectives?
- 31 May 2013
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 98 (6), 828-830
- https://doi.org/10.3324/haematol.2013.090399
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Patient reported outcomes: looking beyond the label claimHealth and Quality of Life Outcomes, 2010
- Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines AgencyEuropean Journal Of Cancer, 2009
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?Haematologica, 2007
- Patient-Reported Outcomes to Support Medical Product Labeling Claims: FDA PerspectiveValue in Health, 2007
- Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth and Quality of Life Outcomes, 2006
- International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)Published by American Society of Hematology ,2006
- Advances in oral therapy for multiple myelomaThe Lancet Oncology, 2006
- Defining Patient-Reported OutcomesValue in Health, 2004
- Beyond the Development of Quality-of-Life Instruments: Where Do We Go From Here?Journal of Clinical Oncology, 2002